Blum J, Desjeux P, Schwartz E, Beck B, Hatz C, 2004. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53 :158–166.

• PubMed
Blum J, Desjeux P, Schwartz E, Beck B, Hatz C, 2004. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53: 158–166.)| false
• Search Google Scholar
• Export Citation

Jeannel D, Tuppin P, Brucker G, Danis M, Gentilini M, 1989. Leishmaniasis in France. Lancet 2 :804.

• PubMed
Jeannel D, Tuppin P, Brucker G, Danis M, Gentilini M, 1989. Leishmaniasis in France. Lancet 2: 804.)| false
• Search Google Scholar
• Export Citation

Bryceson A, 1987. Therapy in man. Peters W, Killick-Kendrick R, eds. The Leishmaniases. London: Elsevier, 847–869.

• PubMed
Bryceson A, 1987. Therapy in man. Peters W, Killick-Kendrick R, eds. The Leishmaniases. London: Elsevier, 847–869.)| false
• Export Citation

Masmoudi A, Maalej N, Mseddi M, Souissi A, Turki H, Boudaya S, Bouassida S, Zahaf A, 2005. Glucantime injection: benefit versus toxicity. Med Mal Infect 35 :42–45.

• PubMed
Masmoudi A, Maalej N, Mseddi M, Souissi A, Turki H, Boudaya S, Bouassida S, Zahaf A, 2005. Glucantime injection: benefit versus toxicity. Med Mal Infect 35: 42–45.)| false
• Search Google Scholar
• Export Citation

Herwaldt BL, Berman JD, 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46 :296–306.

• PubMed
Herwaldt BL, Berman JD, 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296–306.)| false
• Search Google Scholar
• Export Citation

Berman JD, 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24 :684–703.

• PubMed
Berman JD, 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684–703.)| false
• Search Google Scholar
• Export Citation

Sampaio RN, Martins Netto E, Faria E, Sampaio J, de Freitas L, Marsden P, 1988. Sudden death caused by glucantime. An Bras Dermatol 63 :35–37.

• PubMed
Sampaio RN, Martins Netto E, Faria E, Sampaio J, de Freitas L, Marsden P, 1988. Sudden death caused by glucantime. An Bras Dermatol 63: 35–37.)| false
• Search Google Scholar
• Export Citation

Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH, 2002. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346 :891–895.

• PubMed
Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH, 2002. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346: 891–895.)| false
• Search Google Scholar
• Export Citation

Belazzoug S, Neal RA, 1986. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria. Trans R Soc Trop Med Hyg 80 :670–671.

• PubMed
Belazzoug S, Neal RA, 1986. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria. Trans R Soc Trop Med Hyg 80: 670–671.)| false
• Search Google Scholar
• Export Citation

Chahed MK, Ben Salah A, Louzir H, Marrakchi H, Zaatour A, Ftaiti A, Ben Chaabane B, Sidhom M, Dellagi K, Ben Ismail R, 1999. Efficacy of intra-lesional glucantime in the treatment of zoonotic cutaneous leishmaniasis in basic health care conditions. Arch Inst Pasteur Tunis 76 :13–18.

• PubMed
Chahed MK, Ben Salah A, Louzir H, Marrakchi H, Zaatour A, Ftaiti A, Ben Chaabane B, Sidhom M, Dellagi K, Ben Ismail R, 1999. Efficacy of intra-lesional glucantime in the treatment of zoonotic cutaneous leishmaniasis in basic health care conditions. Arch Inst Pasteur Tunis 76: 13–18.)| false
• Search Google Scholar
• Export Citation

Buffet PA, Morizot G, 2003. Cutaneous leishmaniasis in France: towards the end of injectable therapy? Bull Soc Pathol Exot 96 :383–388.

• PubMed
Buffet PA, Morizot G, 2003. Cutaneous leishmaniasis in France: towards the end of injectable therapy? Bull Soc Pathol Exot 96: 383–388.)| false
• Search Google Scholar
• Export Citation

Laffitte E, Genton B, Panizzon RG, 2005. Cutaneous leishmaniasis caused by Leishmania tropica: treatment with oral fluconazole. Dermatology 210: 249–251.

• PubMed
Laffitte E, Genton B, Panizzon RG, 2005. Cutaneous leishmaniasis caused by Leishmania tropica: treatment with oral fluconazole. Dermatology 210: 249–251.)| false
• Search Google Scholar
• Export Citation

Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben Ismail R, 1995. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg 53 :162–166.

• PubMed
Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben Ismail R, 1995. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg 53: 162–166.)| false
• Search Google Scholar
• Export Citation

Momeni AZ, Aminjavaheri M, Omidghaemi MR, 2003. Treatment of cutaneous leishmaniasis with ketoconazole cream. J Dermatolog Treat 14 :26–29.

• PubMed
Momeni AZ, Aminjavaheri M, Omidghaemi MR, 2003. Treatment of cutaneous leishmaniasis with ketoconazole cream. J Dermatolog Treat 14: 26–29.)| false
• Search Google Scholar
• Export Citation

Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P, 1995. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 53 :648–651.

• PubMed
Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P, 1995. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 53: 648–651.)| false
• Search Google Scholar
• Export Citation

Momeni AZ, Jalayer T, Emamjomeh M, Bashardost N, Ghassemi RL, Meghdadi M, Javadi A, Aminjavaheri M, 1996. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study. Arch Dermatol 132 :784–786.

• PubMed
Momeni AZ, Jalayer T, Emamjomeh M, Bashardost N, Ghassemi RL, Meghdadi M, Javadi A, Aminjavaheri M, 1996. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study. Arch Dermatol 132: 784–786.)| false
• Search Google Scholar
• Export Citation

el-Safi SH, Murphy AG, Bryceson AD, Neal RA, 1990. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans R Soc Trop Med Hyg 84 :690–691.

• PubMed
el-Safi SH, Murphy AG, Bryceson AD, Neal RA, 1990. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans R Soc Trop Med Hyg 84: 690–691.)| false
• Search Google Scholar
• Export Citation

Iraji F, Sadeghinia A, 2005. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran. Ann Trop Med Parasitol 99 :3–9.

• PubMed
Iraji F, Sadeghinia A, 2005. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran. Ann Trop Med Parasitol 99: 3–9.)| false
• Search Google Scholar
• Export Citation

Lanotte G, Rioux JA, Maazoun R, Pasteur N, Pratlong F, Lepart J, 1981. Significance of enzymatic polymorphism in Leishmaniae: on three heterozygous stocks of Leishmania infantum Nicolle, 1908, Leishmania cf. tarentolae Wenyon, 1921 and Leishmania aethiopica Bray, Ashford and Bray, 1973. Ann Parasitol Hum Comp 56 :575–591.

• PubMed
Lanotte G, Rioux JA, Maazoun R, Pasteur N, Pratlong F, Lepart J, 1981. Significance of enzymatic polymorphism in Leishmaniae: on three heterozygous stocks of Leishmania infantum Nicolle, 1908, Leishmania cf. tarentolae Wenyon, 1921 and Leishmania aethiopica Bray, Ashford and Bray, 1973. Ann Parasitol Hum Comp 56: 575–591.)| false
• Search Google Scholar
• Export Citation

Lanotte G, Rioux JA, Lepart J, Maazoun R, Pasteur N, Pratlong F, 1984. Numerical cladistics of the phylogeny of the genus Leishmania Ross, 1903 (Kinetoplastida-Trypanosomatidae). Use of enzyme characteristics. C R Acad Sci III 299 :769–772.

• PubMed
Lanotte G, Rioux JA, Lepart J, Maazoun R, Pasteur N, Pratlong F, 1984. Numerical cladistics of the phylogeny of the genus Leishmania Ross, 1903 (Kinetoplastida-Trypanosomatidae). Use of enzyme characteristics. C R Acad Sci III 299: 769–772.)| false
• Search Google Scholar
• Export Citation

Navin TR, Arana BA, Arana FE, Berman JD, Chajon JF, 1992. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 165 :528–534.

• PubMed
Navin TR, Arana BA, Arana FE, Berman JD, Chajon JF, 1992. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 165: 528–534.)| false
• Search Google Scholar
• Export Citation

Martinez S, Marr JJ, 1992. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 326 :741–744.

• PubMed
Martinez S, Marr JJ, 1992. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 326: 741–744.)| false
• Search Google Scholar
• Export Citation

Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J, 1997. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med 126 :232–236.

• PubMed
Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J, 1997. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med 126: 232–236.)| false
• Search Google Scholar
• Export Citation

Martinez S, Gonzalez M, Vernaza ME, 1997. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis 24 :165–169.

• PubMed
Martinez S, Gonzalez M, Vernaza ME, 1997. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis 24: 165–169.)| false
• Search Google Scholar
• Export Citation

Zvulunov A, Klaus S, Vardy D, 2002. Fluconazole for the treatment of cutaneous leishmaniasis. N Engl J Med 347 :370–371.

• PubMed
Zvulunov A, Klaus S, Vardy D, 2002. Fluconazole for the treatment of cutaneous leishmaniasis. N Engl J Med 347: 370–371.)| false
• Search Google Scholar
• Export Citation